One-Carbon Metabolism Nutrients, Genetic Variation, and Diabetes Mellitus

Overview

Journal Diabetes Metab J

Specialty Endocrinology

Date 2024 Mar 12

PMID 38468500

Authors

Jie Zhu

Gunjana Saikia

Xiaotao Zhang

Xiaoxi Shen

Ka Kahe

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus (DM) affects about 9.3% of the population globally. Hyperhomocysteinemia (HHcy) has been implicated in the pathogenesis of DM, owing to its promotion of oxidative stress, β-cell dysfunction, and insulin resistance. HHcy can result from low status of one-carbon metabolism (OCM) nutrients (e.g., folate, choline, betaine, vitamin B6, B12), which work together to degrade homocysteine by methylation. The etiology of HHcy may also involve genetic variation encoding key enzymes in OCM. This review aimed to provide an overview of the existing literature assessing the link between OCM nutrients status, related genetic factors, and incident DM. We also discussed possible mechanisms underlying the role of OCM in DM development and provided recommendations for future research and practice. Even though the available evidence remains inconsistent, some studies support the potential beneficial effects of intakes or blood levels of OCM nutrients on DM development. Moreover, certain variants in OCM-related genes may influence metabolic handling of methyl-donors and presumably incidental DM. Future studies are warranted to establish the causal inference between OCM and DM and examine the interaction of OCM nutrients and genetic factors with DM development, which will inform the personalized recommendations for OCM nutrients intakes on DM prevention.

Citing Articles

Association between chronic kidney disease and oxidative balance score: National Health and Nutrition Examination Survey (NHANES) 2005-2018.

Liu C, Yang J, Li H, Deng Y, He P, Zhang J Front Nutr. 2025; 11():1406780.

PMID: 39830066 PMC: 11738952. DOI: 10.3389/fnut.2024.1406780.

Hyperhomocysteinemia and Disease-Is 10 μmol/L a Suitable New Threshold Limit?.

Marroncini G, Martinelli S, Menchetti S, Bombardiere F, Martelli F Int J Mol Sci. 2024; 25(22).

PMID: 39596358 PMC: 11594664. DOI: 10.3390/ijms252212295.

Choline Metabolites and 15-Year Risk of Incident Diabetes in a Prospective Cohort of Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Sprinkles J, Lulla A, Hullings A, Trujillo-Gonzalez I, Klatt K, Jacobs Jr D Diabetes Care. 2024; 47(11):1985-1994.

PMID: 39259767 PMC: 11502527. DOI: 10.2337/dc24-1033.

Alterations in Choline Metabolism in Non-Obese Individuals with Insulin Resistance and Type 2 Diabetes Mellitus.

Al-Sulaiti H, Anwardeen N, Bashraheel S, Naja K, Elrayess M Metabolites. 2024; 14(8).

PMID: 39195553 PMC: 11356528. DOI: 10.3390/metabo14080457.

Association between oxidative balance score and diabetic kidney disease, low estimated glomerular filtration rate and albuminuria in type 2 diabetes mellitus patients: a cross-sectional study.

Liu C, Yang J, Li H, Deng Y, He P, Zhang J Front Endocrinol (Lausanne). 2024; 15:1412823.

PMID: 39145317 PMC: 11322072. DOI: 10.3389/fendo.2024.1412823.

References

Song Y, Cook N, Albert C, Van Denburgh M, Manson J . Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. Diabetes. 2009; 58(8):1921-8. PMC: 2712772. DOI: 10.2337/db09-0087. View

Cheng C, Wang C, Shang W, Lau C, Luo J, Wang L . A high methionine and low folate diet alters glucose homeostasis and gut microbiome. Biochem Biophys Rep. 2021; 25:100921. PMC: 7838713. DOI: 10.1016/j.bbrep.2021.100921. View

Finer S, Saravanan P, Hitman G, Yajnik C . The role of the one-carbon cycle in the developmental origins of Type 2 diabetes and obesity. Diabet Med. 2013; 31(3):263-72. DOI: 10.1111/dme.12390. View

Doshi S, McDowell I, Moat S, Payne N, Durrant H, Lewis M . Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 2002; 105(1):22-6. DOI: 10.1161/hc0102.101388. View

Moat S, Madhavan A, Taylor S, Payne N, Allen R, Stabler S . High- but not low-dose folic acid improves endothelial function in coronary artery disease. Eur J Clin Invest. 2006; 36(12):850-9. DOI: 10.1111/j.1365-2362.2006.01739.x. View

Ding L, Yang Q, Sun Z, Liu L, Meng Z, Zhao X . Association between dietary intake of one-carbon metabolism nutrients and hyperglycemia in coal-burning fluorosis areas of Guizhou, China. Front Nutr. 2022; 9:1002044. PMC: 9589113. DOI: 10.3389/fnut.2022.1002044. View

Gao X, Randell E, Tian Y, Zhou H, Sun G . Low serum choline and high serum betaine levels are associated with favorable components of metabolic syndrome in Newfoundland population. J Diabetes Complications. 2019; 33(10):107398. DOI: 10.1016/j.jdiacomp.2019.06.003. View

Qin X, Li J, Zhang Y, Chen D, Wang B, He M . Effect of folic acid supplementation on risk of new-onset diabetes in adults with hypertension in China: Findings from the China Stroke Primary Prevention Trial (CSPPT). J Diabetes. 2015; 8(2):286-94. DOI: 10.1111/1753-0407.12346. View

Asemi Z, Karamali M, Esmaillzadeh A . Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Mol Nutr Food Res. 2014; 58(7):1465-73. DOI: 10.1002/mnfr.201400033. View

10.

Nie H, Hu H, Li Z, Wang R, He J, Li P . Associations of plasma metal levels with type 2 diabetes and the mediating effects of microRNAs. Environ Pollut. 2021; 292(Pt B):118452. DOI: 10.1016/j.envpol.2021.118452. View

11.

Huang T, Ren J, Huang J, Li D . Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach. BMC Genomics. 2013; 14:867. PMC: 3878883. DOI: 10.1186/1471-2164-14-867. View

12.

Talari H, Rafiee M, Farrokhian A, Raygan F, Bahmani F, Mofrad M . The Effects of Folate Supplementation on Carotid Intima-Media Thickness and Metabolic Status in Patients with Metabolic Syndrome. Ann Nutr Metab. 2016; 69(1):41-50. DOI: 10.1159/000448295. View

13.

Zhu J, Wu Y, Tang Q, Leng Y, Cai W . The effects of choline on hepatic lipid metabolism, mitochondrial function and antioxidative status in human hepatic C3A cells exposed to excessive energy substrates. Nutrients. 2014; 6(7):2552-71. PMC: 4113756. DOI: 10.3390/nu6072552. View

14.

Esfahani P, Mahdavinia M, Khorsandi L, Rezaei M, Nikravesh H, Khodayar M . Betaine protects against sodium arsenite-induced diabetes and hepatotoxicity in mice. Environ Sci Pollut Res Int. 2022; 30(4):10880-10889. DOI: 10.1007/s11356-022-22941-w. View

15.

Huang T, Tucker K, Lee Y, Crott J, Parnell L, Shen J . Methylenetetrahydrofolate reductase variants associated with hypertension and cardiovascular disease interact with dietary polyunsaturated fatty acids to modulate plasma homocysteine in puerto rican adults. J Nutr. 2011; 141(4):654-9. PMC: 3056580. DOI: 10.3945/jn.110.134353. View

16.

Chong C, Clarke K, Levelt E . Metabolic Remodeling in Diabetic Cardiomyopathy. Cardiovasc Res. 2017; 113(4):422-430. PMC: 5412022. DOI: 10.1093/cvr/cvx018. View

17.

Karamali M, Heidarzadeh Z, Seifati S, Samimi M, Tabassi Z, Hajijafari M . Zinc supplementation and the effects on metabolic status in gestational diabetes: A randomized, double-blind, placebo-controlled trial. J Diabetes Complications. 2015; 29(8):1314-9. DOI: 10.1016/j.jdiacomp.2015.07.001. View

18.

Sun X, Chen Y, Shu J, Li Z, Yu D, Peng W . The Association between Methionine Intake and Diabetes in Chinese Adults-Results from the China Health and Nutrition Survey. Nutrients. 2023; 15(1). PMC: 9823418. DOI: 10.3390/nu15010116. View

19.

Mangoni A, A Sherwood R, Asonganyi B, Swift C, Thomas S, Jackson S . Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens. 2005; 18(2 Pt 1):220-6. DOI: 10.1016/j.amjhyper.2004.08.036. View

20.

Glier M, Green T, Devlin A . Methyl nutrients, DNA methylation, and cardiovascular disease. Mol Nutr Food Res. 2013; 58(1):172-82. DOI: 10.1002/mnfr.201200636. View